Piper Sandler analyst Yasmeen Rahimi downgraded Soleno Therapeutics Inc. (NASDAQ: SLNO) from Overweight to Neutral with a price target of $53.00 (from $145.00).

For an analyst ratings summary and ratings history on Soleno Therapeutics Inc. click here. For more ratings news on Soleno Therapeutics Inc. click here.

Shares of Soleno Therapeutics Inc. closed at $52.25 yesterday.